LRRK2 P755L variant in sporadic Parkinson's disease
- PMID: 18923807
- DOI: 10.1007/s10038-008-0336-5
LRRK2 P755L variant in sporadic Parkinson's disease
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder of unknown etiology with probable involvement of genetic-environmental factors. The majority of PD cases (approximately 90-95%) are sporadic, while familial cases account for approximately 5-10% of PD. In a recent report, a heterozygous LRRK2 P755L mutation within LRRK2 exon 19 was found in 2% of Chinese sporadic PD patients and in 0% of normal controls or Caucasians, suggesting that the mutation is disease-associated with ethnic specificity. To further evaluate the role of LRRK2 P755L variant in sporadic PD, we performed direct sequencing of LRRK2 exon 19 in 501 Japanese sporadic PD patients (male 249, female 252, aged 28-92 years, mean 65.0 years) and 583 controls of the Japanese general population as an extended association study. In this group, we found six patients (6/501 = 1.2%) and eight controls of the general population (8/583 = 1.6%) with a heterozygous P755L variant (P = 0.80, chi(2) = 0.064). No other variants were found in exon 19. Together with previous reports, our extended case-controlled study of large sample size suggests that LRRK2 P755L is a non-disease-associated polymorphism in PD patients.
Similar articles
-
Pathogenicity of LRRK2 P755L variant in Parkinson's disease.Mov Disord. 2008 Apr 15;23(5):734-6. doi: 10.1002/mds.21852. Mov Disord. 2008. PMID: 18265005
-
Genetic analysis of LRRK2 P755L variant in Caucasian patients with Parkinson's disease.Neurosci Lett. 2007 May 29;419(2):104-7. doi: 10.1016/j.neulet.2007.04.026. Epub 2007 Apr 19. Neurosci Lett. 2007. PMID: 17482357
-
A novel P755L mutation in LRRK2 gene associated with Parkinson's disease.Neuroreport. 2006 Dec 18;17(18):1859-62. doi: 10.1097/WNR.0b013e328010521c. Neuroreport. 2006. PMID: 17179858
-
[Clinical molecular genetics for PARK8 (LRRK2)].Brain Nerve. 2007 Aug;59(8):839-50. Brain Nerve. 2007. PMID: 17713120 Review. Japanese.
-
Quantitative assessment of the effect of LRRK2 exonic variants on the risk of Parkinson's disease: a meta-analysis.Parkinsonism Relat Disord. 2012 Jul;18(6):722-30. doi: 10.1016/j.parkreldis.2012.04.013. Epub 2012 May 8. Parkinsonism Relat Disord. 2012. PMID: 22575234 Review.
Cited by
-
Genomic Characteristics of Genetic Creutzfeldt-Jakob Disease Patients with V180I Mutation and Associations with Other Neurodegenerative Disorders.PLoS One. 2016 Jun 24;11(6):e0157540. doi: 10.1371/journal.pone.0157540. eCollection 2016. PLoS One. 2016. PMID: 27341347 Free PMC article.
-
Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.Hum Mutat. 2010 Jul;31(7):763-80. doi: 10.1002/humu.21277. Hum Mutat. 2010. PMID: 20506312 Free PMC article. Review.
-
Neuroprotective Effects of Cranberry Juice Treatment in a Rat Model of Parkinson's Disease.Nutrients. 2022 May 11;14(10):2014. doi: 10.3390/nu14102014. Nutrients. 2022. PMID: 35631155 Free PMC article.
-
Targeting Mitochondria as a Therapeutic Approach for Parkinson's Disease.Cell Mol Neurobiol. 2023 May;43(4):1499-1518. doi: 10.1007/s10571-022-01265-w. Epub 2022 Aug 11. Cell Mol Neurobiol. 2023. PMID: 35951210 Review.
-
Prevention of Parkinson's Disease: From Risk Factors to Early Interventions.CNS Neurol Disord Drug Targets. 2024;23(6):746-760. doi: 10.2174/1871527322666230616092054. CNS Neurol Disord Drug Targets. 2024. PMID: 37326115 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical